Firm, high-density foam roller provides excellent support and stability during stretching and recovery. Helps relax muscles, relieve tension, reduce soreness, improve flexibility, and increase mobility. Ideal for massaging feet, legs, shoulders, arms, and hands anytime, anywhere.

An **Anti-DNase B (Anti-Deoxyribonuclease B) Serum test** measures antibodies produced by the body in response to a group A *Streptococcus* bacterial infection. While a sore throat is the most common presentation, this specific test is exceptionally valuable for detecting recent **streptococcal skin infections (impetigo)**, where other tests like ASOT can sometimes fail.

Evaluating Anti-DNase B levels helps doctors confirm past strep exposure when investigating delayed, serious complications. These include **acute post-streptococcal glomerulonephritis** (a kidney inflammatory disorder) and **rheumatic fever**, ensuring patients receive the correct, targeted long-term care.

An **Anti-Chlamydia trachomatis IgM antibody** test detects the early immune response to *Chlamydia trachomatis*, a common bacterial sexually transmitted infection (STI). Because IgM is the first antibody the immune system produces during an infection, its presence in the blood typically indicates a **recent or active infection**.

While highly useful for identifying acute cases, IgM levels naturally decline as the body transitions to long-term immunity (IgG antibodies). Doctors often pair this test with other diagnostics, like PCR swab tests, to confirm active chlamydia, manage potential complications like pelvic inflammatory disease, and ensure accurate, timely treatment.

The **Anti-CCP (Anti-Cyclic Citrullinated Peptide) test** is a highly specific blood test used primarily to diagnose **Rheumatoid Arthritis (RA)**. It detects autoantibodies that mistakenly target citrullinated proteins, which are formed during joint inflammation.
With a specificity of over 95%, a positive result strongly indicates RA, helping physicians differentiate it from other forms of arthritis early in the disease course. Furthermore, elevated anti-CCP levels are strong prognostic indicators, often predicting a more aggressive, erosive form of joint damage. Early detection via this panel allows for timely therapeutic intervention, significantly improving long-term joint outcomes.

Here is a concise, 100-word product description for the next level of prenatal screening:

The **Ante Natal Panel 2 Diagnostic Test** offers an advanced, secondary tier of comprehensive prenatal screening to meticulously monitor maternal health and fetal well-being during mid-pregnancy. Building upon foundational baseline screenings, this vital panel integrates crucial metabolic and systemic evaluations, including a Gestational Diabetes screening (Glucose Tolerance Test), comprehensive urine analysis for preeclampsia risk, and extended thyroid profiling (TSH). By identifying hidden physiological shifts and potential complications early in the second trimester, this panel empowers healthcare providers to deliver highly targeted, timely interventions, ensuring a secure path forward for both mother and child.

Here is a concise, 100-word product description for an e-commerce or medical listing:

The **Ante Natal Panel 1 Diagnostic Test** is a comprehensive screening profile designed to assess maternal health and ensure optimal fetal development during early pregnancy. This essential panel includes a complete blood count (CBC), blood grouping, Rh typing, and screenings for critical infectious diseases such as HIV, Hepatitis B (HBsAg), and Syphilis (VDRL). By detecting potential risk factors early, this routine test allows healthcare providers to implement timely interventions, preventing complications and supporting a safe, healthy pregnancy journey. Fast, accurate, and reliable, it is the foundational step in proactive prenatal care.

An **ANC Profile Diagnostic Test** (Antenatal Care Profile) is a comprehensive panel of blood and urine tests routine during early pregnancy to monitor maternal health and fetal development. This foundational screening typically includes a complete blood count (CBC), blood grouping, Rh factor determination, and screenings for infectious diseases like HIV, Hepatitis B, and syphilis, alongside blood glucose and urine analysis.

Ordering this profile helps healthcare providers establish a clinical baseline, identify potential risk factors—such as gestational diabetes, anemia, or maternal-fetal blood incompatibility—and implement timely interventions, ensuring a safer pregnancy and healthier outcomes for both mother and child.

**Anal Canal - Large Biopsy (3-6 cm) Diagnostic Test**

An **Anal Canal - Large Biopsy (3-6 cm) Diagnostic Test** is a critical histopathological procedure involving the removal and examination of a significant tissue section, measuring between three and six centimeters, from the anal canal. Unlike smaller samples, this extensive biopsy provides a more comprehensive sampling of large lesions, extensive polyps, or complex ulcers detected during physical or endoscopic examinations. A pathologist meticulously analyzes the extensive specimen to determine if the tissue is benign, inflammatory, or indicative of advanced neoplasia, including large, extensive dysplasia or invasive carcinoma. By providing a detailed map of the lesion’s characteristics and depth, this test is crucial for ensuring accurate diagnosis and guiding large-scale treatment plans.

An **Anal Canal - Medium Biopsy (1-3cm) Diagnostic Test** is a histopathological examination performed on tissue samples measuring between one and three centimeters excised from the anal canal. This diagnostic evaluation is typically ordered by a physician when a physical examination, anoscopy, or sigmoidoscopy reveals abnormal mucosal changes, suspicious lesions, polyps, or persistent ulcers.

A pathologist meticulously analyzes the biopsy specimen under a microscope to identify cellular abnormalities, determining whether the tissue is benign, inflammatory, precancerous, or malignant. This test provides critical data needed to differentiate conditions like anal intraepithelial neoplasia (AIN) from invasive carcinomas, guiding precise treatment planning.

An **Amylase Diagnostic Test** is a routine blood or urine analysis used to measure the levels of amylase, an enzyme primarily produced by the pancreas and salivary glands to help digest carbohydrates. This test is most frequently ordered to evaluate, diagnose, or monitor acute or chronic pancreatitis, a condition characterized by painful inflammation of the pancreas.

Rapidly elevated amylase levels in the bloodstream often signal pancreatic injury, blockages in the pancreatic duct, or other gastrointestinal disorders. By providing quick, reliable metrics, this test serves as a foundational tool for clinicians establishing timely interventions and managing abdominal emergencies.

An **Ampullary Biopsy** is a specialized diagnostic procedure performed to evaluate abnormalities in the ampulla of Vater—the crucial junction where the bile and pancreatic ducts empty into the small intestine. Utilizing Endoscopic Retrograde Cholangiopancreatography (ERCP) or standard endoscopy, a gastroenterologist visualizes the area and extracts small tissue samples.

This precise diagnostic test is critical for differentiating between benign conditions, such as inflammatory tissue or adenomas, and malignant tumors like ampullary carcinoma. By providing definitive histopathological analysis, an ampullary biopsy guides clinicians in formulating accurate, timely treatment plans and ensuring targeted patient care.